SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-062667
Filing Date
2024-05-16
Accepted
2024-05-16 19:35:27
Documents
1
Period of Report
2024-05-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2414703-6_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2414703-6_4seq1.xml 4 5851
  Complete submission text file 0001104659-24-062667.txt   7285
Mailing Address 750 LEXINGTON AVE NEW YORK NY 10022
Business Address
WEISS MICHAEL S (Reporting) CIK: 0001038977 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38128 | Film No.: 24957371

Mailing Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453
Business Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453 781-652-4500
Checkpoint Therapeutics, Inc. (Issuer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)